‹ Back to the team's academic timeline
PAPER BRIEF · Research digest
Parkinson's disease: where the voice changes
The physical significance of acoustic parameters and its clinical significance of dysarthria in Parkinson's disease. · Scientific reports
Speech impairment (dysarthria) accompanies nearly all Parkinson's progression, yet subtle voice-quality changes are often overlooked clinically. The 2020 Scientific Reports study asked a concrete question: which acoustic-parameter changes matter?
The study recruited 35 Parkinson's patients and 26 controls for mono-, di- and polysyllabic phonation tasks; logistic regression then separated "protective" from "risk" factors among the acoustic parameters. The patient group differed significantly in mean/maximum/minimum F0, jitter, speech duration and median intensity.
These results show that a quantifiable acoustic indicator set can characterize dysarthria change in Parkinson's disease and point toward new biomarkers. The evidence is exploratory: 35+26 participants, group differences and associations — not validation of a diagnostic tool, let alone individual screening capability.
On authorship: the CV entry marks * after Shu YANG, Fengbo WANG, Liqiong YANG and Fan XU. This site records the marks without interpreting them as co-first or corresponding authorship; meanings and roles follow the published footnotes. The company had no involvement; posted as "team research updates", not as a source of company technology.
Fact-checking boundaries
- 35/26 cases, three syllable tasks, logistic regression and the differing-parameter list all come from the abstract.
- The * in the CV entry is not sufficient evidence of co-first authorship; no contribution or corresponding-author status is inferred.
- "Does not constitute screening capability" is this site's boundary wording, not a sentence from the paper.
Paper abstract (original)
Dysarthria is universal in Parkinson's disease (PD) during disease progression; however, the quality of vocalization changes is often ignored. Furthermore, the role of changes in the acoustic parameters of phonation in PD patients remains unclear. We recruited 35 PD patients and 26 healthy controls to perform single, double, and multiple syllable tests. A logistic regression was performed to differentiate between protective and risk factors among the acoustic parameters. The results indicated that the mean f0, max f0, min f0, jitter, duration of speech and median intensity of speaking for the PD patients were significantly different from those of the healthy controls. These results reveal some promising indicators of dysarthric symptoms consisting of acoustic parameters, and they strengthen our understanding about the significance of changes in phonation by PD patients, which may accelerate the discovery of novel PD biomarkers.